Barclays’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.03M | Buy |
|
|||||
|
2025
Q2 | $1.52M | Buy |
|
|||||
|
2025
Q1 | $1.9M | Sell |
|
|||||
|
2024
Q4 | $4.57M | Buy |
|
|||||
|
2024
Q3 | $5.68M | Buy |
|
|||||
|
2024
Q2 | $2.22M | Buy |
|
|||||
|
2024
Q1 | $3.78M | Sell |
|
|||||
|
2023
Q4 | $6.8M | Buy |
|
|||||
|
2023
Q3 | $3.45M | Buy |
|
|||||
|
2023
Q2 | $3.73M | Buy |
|
|||||
|
2023
Q1 | $2.55M | Sell |
|
|||||
|
2022
Q4 | $4.03M | Buy |
|
|||||
|
2022
Q3 | $3.74M | Buy |
|
|||||
|
2022
Q2 | $479K | Sell |
|
|||||
|
2022
Q1 | $1.22M | Buy |
|
|||||
|
2021
Q4 | $114K | Sell |
|
|||||
|
2021
Q3 | $761K | Sell |
|
|||||
|
2021
Q2 | $2.35M | Buy |
|
|||||
|
2021
Q1 | $2.17M | Buy |
|
|||||
|
2020
Q4 | $3.09M | Buy |
|
|||||
|
2020
Q3 | $1.94M | Sell |
|
|||||
|
2020
Q2 | $5.28M | Buy |
|
|||||
|
2020
Q1 | $3.65M | Sell |
|
|||||
|
2019
Q4 | $5.8M | Buy |
|
|||||
|
2019
Q3 | $1.92M | Buy |
|
|||||
|
2019
Q2 | $1.84M | Buy |
|
|||||
|
2019
Q1 | $534K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $539K | Buy |
|
|||||
|
2018
Q2 | $167K | Sell |
|
|||||
|
2018
Q1 | $291K | Sell |
|
|||||
|
2017
Q4 | $286K | Buy |
|
|||||
|
2017
Q3 | $25K | Buy |
|
|||||
|
2017
Q2 | $0 | Sell |
|
|||||
|
2017
Q1 | $11K | Sell |
|
|||||
|
2016
Q4 | $18K | Sell |
|
|||||
|
2016
Q3 | $124K | Sell |
|
|||||
|
2016
Q2 | $623K | Buy |
|
|||||
|
2016
Q1 | $1K | Sell |
|
|||||
|
2015
Q4 | $5K | Buy |
|
|||||
|
2015
Q3 | $1K | Sell |
|
|||||
|
2015
Q2 | $8K | Buy |
|